The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GLP-1 receptor agonists for primary prevention of breast cancer in high-risk women: A real-world analysis of efficacy and safety.
 
Nico-al Gotera
No Relationships to Disclose
 
Colton Jones
No Relationships to Disclose
 
Jonathan Gelfond
No Relationships to Disclose
 
Vanessa Velazquez
No Relationships to Disclose
 
Ariana Neely
No Relationships to Disclose
 
Jonathan Dao
No Relationships to Disclose
 
Yajur Arya
No Relationships to Disclose
 
Arshi Syal
No Relationships to Disclose
 
Marcela Mazo- Canola
Consulting or Advisory Role - AstraZeneca; Lilly
Speakers' Bureau - AstraZeneca; Gilead Sciences; Stemline Therapeutics
Research Funding - American Cancer Society (Inst); UT San Antonio (Inst)
(OPTIONAL) Uncompensated Relationships - pink fund ( non profit)
 
Virginia Kaklamani
Honoraria - AstraZeneca; daichi; Genentech; Gilead Sciences; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; Lilly; Menarini
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Gilead Sciences; Novartis; Pfizer
Research Funding - Eisai
 
Saba Shaikh
No Relationships to Disclose